Together, Boehringer Ingelheim and Roche will leverage complementary expertise and innovative LNA technology to bring novel treatment approaches to IBD patients. Source: BioSpace

A little less than two years after tying up a multi-billion deal with Sanofi, DiCE Molecules scored another collaborative deal. Source: BioSpace

Should you invest the way billionaire investors do? Source: BioSpace

The fact that Roche has separate R&D units has been the topic of second-guessing on the part of observers and analysts. Source: BioSpace

Array BioPharma announced today that it has entered into a clinical trial collaboration agreement with Pfizer to investigate the safety and efficacy of several novel anti-cancer combinations. Source: BioSpace

The round was co-led by funds managed by new investor Janus Henderson Investors. Source: BioSpace

Investors are salivating at the possibility of a hot merger-and-acquisition market in 2018. Source: BioSpace

The five top-selling drugs brought in a combined $48B so far this year. Source: BioSpace

Chiome Bioscience says it announces termination of candidate antibody related joint research contract, which was signed between the co and Chugai Pharma, as the contract has expired on Dec. 31…

The possibility of a tax bill being passed has many investors and analysts forecasting 2018 to be a big year for mergers and acquisitions. Source: BioSpace